A Senate committee approved an amended proposal on Tuesday intended to prevent manufacturers and wholesale drug distributors from engaging in price gouging when selling off-patent or generic drugs.
COVID-19 vaccine benefits far outweigh ‘rare risk’ of heart inflammation, doctor says
The U.S. Food and Drug Administration is adding a warning for the Pfizer and Moderna COVID-19 vaccines due to rare